Search research articles
Contact Us
Filters
Showing results (741-750 of 807) with videos related to
Page
of 81
Sort By:
Annals of Neurology
|
December 26, 2006
Nemaline myopathy caused by absence of alpha-skeletal muscle actin
Kristen J Nowak, Caroline A Sewry, Carmen Navarro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 21, 2025
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology
Alexandra C Bayer, Liliana M Sanmarco, Alex Pellerin, et al.
Annals of Clinical and Translational Neurology
|
August 23, 2016
Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
Jae-Yun Lee, Panos Stathopoulos, Sasha Gupta, et al.
Cell
|
May 20, 1998
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome
R Varon, C Vissinga, M Platzer, et al.
Leukemia
|
July 1, 2017
BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells
B Sun, W Fiskus, Y Qian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 12, 2012
Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis
Geert O Janssens, Marc H Jansen, Selmer J Lauwers, et al.
Genomics
|
November 15, 1994
A YAC contig spanning the ataxia-telangiectasia locus (groups A and C) at 11q22-q23
G Rotman, K Savitsky, Y Ziv, et al.
Acta Neuropathologica
|
May 2, 2015
Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function
Tamar E Sztal, Mo Zhao, Caitlin Williams, et al.
The Lancet. Neurology
|
January 25, 2025
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.
Muscle & Nerve
|
February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.
Page
of 81
Search research articles
Search
Showing results (741-750 of 807) with videos related to
Sort By:
Page
of 81
Annals of Neurology
|
December 26, 2006
Nemaline myopathy caused by absence of alpha-skeletal muscle actin
Kristen J Nowak, Caroline A Sewry, Carmen Navarro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 21, 2025
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology
Alexandra C Bayer, Liliana M Sanmarco, Alex Pellerin, et al.
Annals of Clinical and Translational Neurology
|
August 23, 2016
Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
Jae-Yun Lee, Panos Stathopoulos, Sasha Gupta, et al.
Cell
|
May 20, 1998
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome
R Varon, C Vissinga, M Platzer, et al.
Leukemia
|
July 1, 2017
BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells
B Sun, W Fiskus, Y Qian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 12, 2012
Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis
Geert O Janssens, Marc H Jansen, Selmer J Lauwers, et al.
Genomics
|
November 15, 1994
A YAC contig spanning the ataxia-telangiectasia locus (groups A and C) at 11q22-q23
G Rotman, K Savitsky, Y Ziv, et al.
Acta Neuropathologica
|
May 2, 2015
Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function
Tamar E Sztal, Mo Zhao, Caitlin Williams, et al.
The Lancet. Neurology
|
January 25, 2025
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.
Muscle & Nerve
|
February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.
Page
of 81